An Unusual Presentation of a Corpus Luteum Rupture

Parth Godhiwala1, Himanshi Agarwal2, Sourya Acharya1

  • 1Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Wardha, Maharashtra, India.

Insights

Rheumatic heart disease patients on anticoagulants face rare gynecological bleeding risks. A case highlights ovulatory bleeding causing hemoperitoneum in a mitral valve replacement patient.

Area of Science:

  • Cardiology
  • Gynecology
  • Hematology

Background:

  • Rheumatic heart disease (RHD) is prevalent in India, often leading to mitral valve replacement (MVR).
  • Anticoagulant therapy post-MVR increases the risk of drug-induced coagulopathy.
  • Gynecological hemorrhage is a rare but serious complication in women of reproductive age on anticoagulants.

Observation:

  • A 30-year-old woman with MVR on anticoagulants presented with congestive cardiac failure.
  • Massive hemoperitoneum was diagnosed via ultrasound-guided paracentesis.
  • Bleeding from a corpus luteal cyst, indicative of ovulatory bleeding, was identified as the cause.

Findings:

  • The patient's ascites and hemoperitoneum were attributed to normal ovulatory bleeding.
  • This rare complication underscores the interplay between cardiac management and gynecological events.
  • Coagulopathy-related hemorrhage can manifest with significant intra-abdominal bleeding.

Implications:

  • Highlights the need for vigilance regarding gynecological bleeding in women on anticoagulation post-MVR.
  • Suggests considering ovulatory events as a potential cause of hemoperitoneum in at-risk patients.
  • Emphasizes multidisciplinary management for complex cardiac and gynecological cases.

Related Concept Videos

Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
2.0K
Ovaries01:26

Ovaries

The ovaries are roughly the size of almonds and measure approximately 2 to 3 centimeters in length. These paired structures are situated within the pelvic region and are anchored by the mesovarium—a peritoneal extension that also connects them to the wider structure of the broad ligament. The support system extends to the suspensory ligament, housing blood and lymphatic vessels. In addition, the ovarian ligament tethers the ovaries to the uterus.
On the ovarian surface, a layer of...
1.4K
Secretory Phase01:19

Secretory Phase

The secretory phase of the menstrual cycle, spanning from day 14 to 28 in a typical 28-day cycle, is a period of significant physiological changes in the female reproductive system. This phase commences immediately after ovulation and is characterized by the preparation of the endometrium for potential embryo implantation.
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
1.4K
Uterus and Cervix01:18

Uterus and Cervix

The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
2.3K